SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 86 filers reported holding SERES THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,695,418 | -44.7% | 9,535,890 | +11.3% | 0.00% | -50.0% |
Q2 2023 | $41,026,039 | +92.0% | 8,564,935 | +127.3% | 0.00% | +100.0% |
Q1 2023 | $21,366,312 | -58.2% | 3,768,309 | -58.7% | 0.00% | -50.0% |
Q4 2022 | $51,118,356 | +113.4% | 9,128,278 | +144.6% | 0.00% | 0.0% |
Q3 2022 | $23,956,000 | +376.9% | 3,731,521 | +154.8% | 0.00% | – |
Q2 2022 | $5,023,000 | -85.4% | 1,464,345 | -69.8% | 0.00% | -100.0% |
Q1 2022 | $34,517,000 | -13.4% | 4,847,943 | +1.3% | 0.00% | 0.0% |
Q4 2021 | $39,864,000 | -42.7% | 4,785,589 | -52.2% | 0.00% | -50.0% |
Q3 2021 | $69,624,000 | -15.7% | 10,003,391 | +188.8% | 0.00% | 0.0% |
Q2 2021 | $82,623,000 | +19.0% | 3,464,273 | +2.8% | 0.00% | 0.0% |
Q1 2021 | $69,405,000 | -21.8% | 3,370,820 | -6.9% | 0.00% | -20.0% |
Q4 2020 | $88,741,000 | +240.9% | 3,622,072 | +293.9% | 0.01% | +150.0% |
Q3 2020 | $26,030,000 | +569.3% | 919,469 | +12.6% | 0.00% | – |
Q2 2020 | $3,889,000 | +63.8% | 816,919 | +22.9% | 0.00% | – |
Q1 2020 | $2,374,000 | -2.2% | 664,916 | -5.5% | 0.00% | – |
Q4 2019 | $2,427,000 | +5.6% | 703,400 | +22.7% | 0.00% | – |
Q3 2019 | $2,299,000 | +55.5% | 573,351 | +24.9% | 0.00% | – |
Q2 2019 | $1,478,000 | -46.4% | 458,976 | +14.4% | 0.00% | – |
Q1 2019 | $2,756,000 | +57.5% | 401,114 | +3.6% | 0.00% | – |
Q4 2018 | $1,750,000 | -41.1% | 387,209 | -1.0% | 0.00% | – |
Q3 2018 | $2,972,000 | -5.7% | 391,273 | +6.8% | 0.00% | – |
Q2 2018 | $3,150,000 | +17.3% | 366,319 | +0.2% | 0.00% | – |
Q1 2018 | $2,685,000 | -26.8% | 365,534 | +0.9% | 0.00% | – |
Q4 2017 | $3,670,000 | -33.6% | 362,102 | +5.1% | 0.00% | – |
Q3 2017 | $5,529,000 | +52.0% | 344,605 | +7.1% | 0.00% | – |
Q2 2017 | $3,637,000 | +12.2% | 321,699 | +12.0% | 0.00% | – |
Q1 2017 | $3,241,000 | +18.6% | 287,306 | +4.1% | 0.00% | – |
Q4 2016 | $2,733,000 | -14.2% | 275,970 | +6.4% | 0.00% | – |
Q3 2016 | $3,186,000 | -57.0% | 259,299 | +1.6% | 0.00% | -100.0% |
Q2 2016 | $7,408,000 | +140.4% | 255,095 | +120.0% | 0.00% | – |
Q1 2016 | $3,081,000 | -24.4% | 115,964 | -0.2% | 0.00% | – |
Q4 2015 | $4,078,000 | +47.0% | 116,203 | +24.3% | 0.00% | – |
Q3 2015 | $2,774,000 | – | 93,511 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 21,571,764 | $610,696,000 | 16.87% |
RA Capital Management | 4,750,000 | $134,473,000 | 2.46% |
ARK Investment Management | 12,293,033 | $348,016,000 | 2.06% |
Opaleye Management Inc. | 335,312 | $9,493,000 | 1.86% |
Sio Capital Management, LLC | 316,800 | $8,969,000 | 1.78% |
Ikarian Capital, LLC | 762,400 | $21,585,000 | 1.56% |
Nikko Asset Management Americas, Inc. | 5,531,670 | $152,176,000 | 1.35% |
EAM Global Investors LLC | 121,629 | $3,443,000 | 1.26% |
EAM Investors, LLC | 133,591 | $3,782,000 | 0.90% |
GILDER GAGNON HOWE & CO LLC | 3,185,420 | $90,179,000 | 0.56% |